Lv1
60 积分 2022-03-21 加入
Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials
1个月前
已完结
IGF-1R Inhibitor IBI311 for the Treatment of Active Thyroid Eye Disease in Chinese Patients
1个月前
已完结
Screening for Latent Tuberculosis Infection in Adults: US Preventive Services Task Force Recommendation Statement
3个月前
已完结
Perioperative Safety and Efficacy of Efgartigimod for Thymoma-Associated Myasthenia Gravis: A Prospective, Multicenter, Phase II Clinical Trial
5个月前
已完结
Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial
5个月前
已完结
Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study
6个月前
已完结
Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study
6个月前
已完结
High risk of activation of latent tuberculosis infection in rheumatic disease patients
6个月前
已完结
综合医疗机构结核病发病高危人群的预防性治疗专家共识
6个月前
已完结
Teclistamab in relapsed systemic sclerosis after autologous haematopoietic stem cell transplantation
7个月前
已完结
皖公网安备34019202002308
